Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Dermatology
•
Genetics
•
Ehlers Danlos Syndrome
•
Hypermobility
What clinical features help distinguish classical or vascular EDS from hypermobile EDS in patients presenting with joint hypermobility?
Related Questions
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
What specific historical questions do you prioritize when evaluating hair loss to identify features suggestive of autoimmune or connective tissue disorders?
What are useful clinical features that help differentiate mechanics hands from other conditions such as hand dermatitis or psoriasis?
What are your vaccine recommendations while patients are on biologics?
How often do you recommend ophthalmologic screening exams for patients with sarcoidosis?
With the increasing availability of biosimilars and their adoption onto payer formularies, how do you approach selection among available biosimilars in clinical practice?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
